Misha Miller, MD
MOHS-Micrographic Surgery · Denver, CONPI 1194802371
Payments from drug & device makers
What this record shows
19 manufacturers reported payments, led by Pfizer at 57.7% of the total. Reporting peaked in 2020 at $2,700 and has fallen 78.0% since, to $593 in 2025.
Across 77 payments — averaging $63.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- AbbVie$535
- Sanofi$223
- Sun Pharmaceutical Industries Inc.$205
- Lilly USA, LLC$190
- Regeneron Healthcare Solutions, Inc.$184
- plus $732 from 13 others
What the payments were for
- Speaking & faculty fees$2,70055%
- Food & beverage$2,19345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $2,822 |
| AbbVie | 22 | $535 |
| Sanofi | 4 | $223 |
| Sun Pharmaceutical Industries Inc. | 6 | $205 |
| Lilly USA, LLC | 4 | $190 |
| Regeneron Healthcare Solutions, Inc. | 7 | $184 |
| Amgen | 5 | $134 |
| Incyte Corporation | 7 | $120 |
| UCB, Inc. | 3 | $86 |
| Strata Skin Sciences, Inc. | 1 | $77 |
| Johnson & Johnson | 3 | $62 |
| Dermavant Sciences, Inc. | 4 | $61 |
| Novartis | 2 | $47 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Boehringer Ingelheim | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| LEO Pharma Inc. | 1 | $20 |
| Springworks Therapeutics, Inc. | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$242
- LITFULO$122
- LEVULAN KERASTICK$121
- OLUMIANT$121
- Rinvoq$104
How this compares
$4,893 in reported general payments places this provider in the 80th percentile of 37 mohs-micrographic surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 38 | $1,428 |
| Fluorouracil | 17 | $1,242 |
| Cephalexin | 138 | $849 |
| Doxycycline Monohydrate | 71 | $570 |
| Triamcinolone Acetonide | 13 | $149 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Denver
- Milton SchleveDenver$3K
- Renee PrideDenver$2K
- Karen SundbyDenver$69
- Joel CohenGreenwood Village$426K
- Shawn AllenBoulder$69K
- Kevin MottLoveland$33K
- Karen NernEdwards$28K
- Vinh ChungColorado Springs$10K
- Brett MathesonColorado Spgs$10K
- Joseph WildeFort Collins$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.